Leerink Partnrs Issues Optimistic Forecast for ARCT Earnings
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) – Research analysts at Leerink Partnrs lifted their Q2 2025 earnings per share estimates for Arcturus Therapeutics in a research note issued on Monday, May 12th. Leerink Partnrs analyst L. Nsongo now anticipates that the biotechnology company will post earnings per share of ($0.88) for the quarter, […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) – Research analysts at Leerink Partnrs lifted their Q2 2025 earnings per share estimates for Arcturus Therapeutics in a research note issued on Monday, May 12th. Leerink Partnrs analyst L. Nsongo now anticipates that the biotechnology company will post earnings per share of ($0.88) for the quarter, […]
